WHITNEY FRAME: Open Payments
NPI 1336798792 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 33 payments from 15 companies in 2025. Trend: 2023 $552 · 2024 $674 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $165 |
| ABBVIE INC. | 5 | $94 |
| Lundbeck LLC | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Amgen Inc. | 2 | $30 |
| Exact Sciences Corporation | 2 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: REXULTI, VRAYLAR, Ozempic, Wegovy, CAPLYTA, EVENITY, Rybelsus, INGREZZA.
Industry payments across IN — which companies pay providers there.
